NO20002351D0 - Nye substituerte pyridin- eller piperidinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem - Google Patents

Nye substituerte pyridin- eller piperidinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem

Info

Publication number: NO20002351D0
Authority: NO; Norway
Prior art keywords: group; alkoxy; pyridine; piperidine; preparation
Prior art date: 1999-05-05

Application number

NO20002351A

Other languages

English (en)

Other versions

NO20002351L (no

NO317095B1 (no

Inventor

Otto Meth-Cohn

Chu-Yi Yu

Pierre Lestage

Marie-Cecile Lebrun

Daniel-Henri Caignard

Pierre Renard

Original Assignee

Adir

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-05

Filing date

2000-05-04

Publication date

2000-05-04

2000-05-04 Application filed by Adir filed Critical Adir

2000-05-04 Publication of NO20002351D0 publication Critical patent/NO20002351D0/no

2000-11-06 Publication of NO20002351L publication Critical patent/NO20002351L/no

2004-08-09 Publication of NO317095B1 publication Critical patent/NO317095B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

NO20002351A 1999-05-05 2000-05-04 Nye substituerte pyridin- eller piperidinforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem NO317095B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9905690A FR2793245B1 (fr)	1999-05-05	1999-05-05	Nouveaux composes pyridiniques ou piperidiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number	Publication Date
NO20002351D0 true NO20002351D0 (no)	2000-05-04
NO20002351L NO20002351L (no)	2000-11-06
NO317095B1 NO317095B1 (no)	2004-08-09

Family

ID=9545222

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20002351A NO317095B1 (no)	1999-05-05	2000-05-04	Nye substituerte pyridin- eller piperidinforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Country Status (22)

Country	Link
US (6)	US6323220B1 (no)
EP (1)	EP1050531B1 (no)
JP (2)	JP3533361B2 (no)
KR (1)	KR100472519B1 (no)
CN (1)	CN100371326C (no)
AT (1)	ATE282595T1 (no)
AU (1)	AU764388B2 (no)
BR (1)	BR0002287A (no)
CA (1)	CA2308867C (no)
DE (1)	DE60015844T2 (no)
DK (1)	DK1050531T3 (no)
EA (1)	EA003053B1 (no)
ES (1)	ES2233302T3 (no)
FR (1)	FR2793245B1 (no)
HU (1)	HUP0001789A3 (no)
MX (1)	MXPA00004343A (no)
NO (1)	NO317095B1 (no)
NZ (1)	NZ504338A (no)
PL (1)	PL197661B1 (no)
PT (1)	PT1050531E (no)
SI (1)	SI1050531T1 (no)
ZA (1)	ZA200002207B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7687513B1 (en)	2004-10-21	2010-03-30	University Of Notre Dame Du Lac	Aminopyridinium ionic liquids
US7812098B2 (en) *	2006-03-31	2010-10-12	Depuy Products, Inc.	Bearing material of medical implant having reduced wear rate and method for reducing wear rate
FR2905009A1 (fr) *	2006-08-18	2008-02-22	Servier Lab	Methode de criblage de composes aux proprietes anti-amyloide
US20090118331A1 (en) *	2007-11-02	2009-05-07	Crooks Peter A	Use of Lobeline Epimers in the Treatment of Central Nervous System Diseases, Pathologies, and Drug Abuse
WO2009061906A2 (en) *	2007-11-06	2009-05-14	Mayo Foundation For Medical Education And Research	Treating protein misfolding diseases
EP2186419A1 (en) *	2008-11-13	2010-05-19	Tchibo GmbH	NMP-containing extract, a method of its production and uses thereof
WO2010087313A1 (ja) *	2009-01-29	2010-08-05	株式会社林原生物化学研究所	神経突起伸展促進剤
JPWO2010087315A1 (ja) *	2009-01-29	2012-08-02	株式会社林原生物化学研究所	抗アルツハイマー病剤
JP5591720B2 (ja) *	2009-01-29	2014-09-17	株式会社林原	抗神経変性疾患剤
CN113966217A (zh) *	2019-06-14	2022-01-21	达萨玛治疗公司	Sarm1抑制剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3840523A (en) *	1973-04-25	1974-10-08	Richardson Merrell Inc	Tricyclic arylalkylene lactamimides
US4082806A (en)	1975-12-18	1978-04-04	Wright State University	Preparation of tetraketones
JPS5328177A (en) *	1976-08-25	1978-03-16	Teijin Ltd	Optical active piperidine derivatives and their preparation
EP0336886B1 (de) *	1988-03-16	1992-08-26	Ciba-Geigy Ag	Thioverbindungen
ES2051927T3 (es) *	1988-06-14	1994-07-01	Searle & Co	1,2-diariletilaminas para el tratamiento de daños neurotoxicos.
JP2522690B2 (ja)	1988-06-16	1996-08-07	富士写真フイルム株式会社	ハロゲン化銀カラ―写真感光材料
US5414005A (en) *	1993-10-28	1995-05-09	Dynagen, Inc.	Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation
GB9304919D0 (en) *	1993-03-10	1993-04-28	Celltech Ltd	Chemical compounds
FR2756826B1 (fr) *	1996-12-05	1999-01-08	Adir	Nouveaux derives tetrahydropyridiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5830904A (en) *	1997-02-05	1998-11-03	University Of Kentucky Research Foundation	Lobeline compounds as a treatment for psychostimulant abuse and withdrawal, and for eating disorders
US6087376A (en) *	1997-02-05	2000-07-11	University Of Kentucky Research Foundation	Use of lobeline compounds in the treatment of central nervous system diseases and pathologies
EP1014981A1 (en) *	1997-02-07	2000-07-05	Synapse Pharmaceuticals International, Inc.	Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
JPH10287634A (ja) *	1997-04-11	1998-10-27	Otsuka Pharmaceut Co Ltd	ベンゼン誘導体
TW544448B (en) *	1997-07-11	2003-08-01	Novartis Ag	Pyridine derivatives
ATE224366T1 (de) *	1997-10-31	2002-10-15	Hoffmann La Roche	D-prolinderivate
US6015824A (en) *	1998-02-10	2000-01-18	Hoffmann-La Roche Ag	Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders

1999
- 1999-05-05 FR FR9905690A patent/FR2793245B1/fr not_active Expired - Fee Related
2000
- 2000-04-30 CN CNB001181572A patent/CN100371326C/zh not_active Expired - Fee Related
- 2000-05-02 EP EP00401198A patent/EP1050531B1/fr not_active Expired - Lifetime
- 2000-05-02 PT PT00401198T patent/PT1050531E/pt unknown
- 2000-05-02 SI SI200030565T patent/SI1050531T1/xx unknown
- 2000-05-02 AT AT00401198T patent/ATE282595T1/de not_active IP Right Cessation
- 2000-05-02 ES ES00401198T patent/ES2233302T3/es not_active Expired - Lifetime
- 2000-05-02 DE DE60015844T patent/DE60015844T2/de not_active Expired - Fee Related
- 2000-05-02 DK DK00401198T patent/DK1050531T3/da active
- 2000-05-02 JP JP2000133762A patent/JP3533361B2/ja not_active Expired - Fee Related
- 2000-05-03 KR KR10-2000-0023682A patent/KR100472519B1/ko not_active IP Right Cessation
- 2000-05-04 PL PL339994A patent/PL197661B1/pl not_active IP Right Cessation
- 2000-05-04 NZ NZ504338A patent/NZ504338A/en unknown
- 2000-05-04 NO NO20002351A patent/NO317095B1/no unknown
- 2000-05-04 US US09/564,527 patent/US6323220B1/en not_active Expired - Fee Related
- 2000-05-04 MX MXPA00004343A patent/MXPA00004343A/es active IP Right Grant
- 2000-05-04 EA EA200000389A patent/EA003053B1/ru not_active IP Right Cessation
- 2000-05-05 HU HU0001789A patent/HUP0001789A3/hu unknown
- 2000-05-05 CA CA002308867A patent/CA2308867C/fr not_active Expired - Fee Related
- 2000-05-05 ZA ZA200002207A patent/ZA200002207B/xx unknown
- 2000-05-05 AU AU32552/00A patent/AU764388B2/en not_active Ceased
- 2000-05-05 BR BR0002287-0A patent/BR0002287A/pt not_active Application Discontinuation
2001
- 2001-09-25 US US09/962,376 patent/US6638946B2/en not_active Expired - Fee Related
- 2001-09-25 US US09/963,018 patent/US6511992B2/en not_active Expired - Fee Related
- 2001-10-17 JP JP2001319183A patent/JP2002179652A/ja active Pending
2002
- 2002-11-27 US US10/306,024 patent/US6734196B2/en not_active Expired - Fee Related
2003
- 2003-03-03 US US10/377,843 patent/US20030181484A1/en not_active Abandoned
2004
- 2004-05-13 US US10/844,856 patent/US20050004168A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US6323220B1 (en)	2001-11-27
NO20002351L (no)	2000-11-06
CA2308867C (fr)	2006-03-14
EP1050531A1 (fr)	2000-11-08
US6511992B2 (en)	2003-01-28
US20020035123A1 (en)	2002-03-21
DE60015844D1 (de)	2004-12-23
DK1050531T3 (da)	2005-03-21
KR20010020808A (ko)	2001-03-15
DE60015844T2 (de)	2005-10-27
KR100472519B1 (ko)	2005-03-07
HUP0001789A2 (en)	2001-03-28
ATE282595T1 (de)	2004-12-15
US6734196B2 (en)	2004-05-11
AU3255200A (en)	2000-11-09
NO317095B1 (no)	2004-08-09
PT1050531E (pt)	2005-03-31
JP2002179652A (ja)	2002-06-26
US20030139408A1 (en)	2003-07-24
US20030181484A1 (en)	2003-09-25
PL197661B1 (pl)	2008-04-30
HU0001789D0 (en)	2000-07-28
EP1050531B1 (fr)	2004-11-17
FR2793245A1 (fr)	2000-11-10
ES2233302T3 (es)	2005-06-16
CN100371326C (zh)	2008-02-27
NZ504338A (en)	2001-06-29
US6638946B2 (en)	2003-10-28
US20020040036A1 (en)	2002-04-04
MXPA00004343A (es)	2002-03-08
FR2793245B1 (fr)	2002-10-11
EA200000389A2 (ru)	2000-12-25
SI1050531T1 (en)	2005-04-30
ZA200002207B (en)	2000-11-14
AU764388B2 (en)	2003-08-14
PL339994A1 (en)	2000-11-06
JP3533361B2 (ja)	2004-05-31
JP2000355579A (ja)	2000-12-26
EA200000389A3 (ru)	2001-02-26
BR0002287A (pt)	2001-01-02
CA2308867A1 (fr)	2000-11-05
US20050004168A1 (en)	2005-01-06
EA003053B1 (ru)	2002-12-26
CN1277192A (zh)	2000-12-20
HUP0001789A3 (en)	2004-04-28

Publication	Publication Date	Title
US3773773A (en)	1973-11-20	N-alkyl-1,4-dihydropyridines and their production
CA2450922A1 (en)	2001-12-20	Piperidines for use as orexin receptor antagonists
DK131893A (da)	1993-11-24	2-(Substitueret methyl)-4-(substitueret ethoxy)-5-(lavere alkyl)-pyridinforbindelser, farmaceutisk præparat, som indeholder sådanne samt anvendelse af en sådan forbindelse til fremstilling af et farmaceutisk præparat
KR870001196A (ko)	1987-03-12	피리딘 화합물과 그의 제법 및 그를 함유하는 약학조성물
MEP22008A (en)	2010-06-10	Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
RU2006101890A (ru)	2007-07-27	Производные тиазолилпиперидина в качестве ингибиторов мпб
RU98119523A (ru)	2000-10-20	Соединения пиперазина и пиперидина
RU98117621A (ru)	2000-06-20	Новые производные пиперазина и пиперидина, способ их получения, фармкомпозиция на их основе, способ лечения, промежуточный продукт
NO20005166D0 (no)	2000-10-13	Nye benzotiofen-, benzofuran- og indolforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
KR930005992A (ko)	1993-04-20	루코트리엔 생합성 억제제
DE60223245D1 (de)	2007-12-13	Thiazol- und oxazolderivate, die sich für die behandlung von herzkreislauferkrankungen und ähnlichen erkrankungen eignen
FR2844270B1 (fr)	2006-05-19	Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
NO20002351D0 (no)	2000-05-04	Nye substituerte pyridin- eller piperidinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
NO331165B1 (no)	2011-10-24	Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter
KR920016422A (ko)	1992-09-24	N-페닐카바메이트 화합물, 이의 제조방법 및 유해한 유기체를 방제하기 위한 살균 조성물
DK355784A (da)	1985-01-24	2-(heterocyclylalkoxymethyl)-4-(aryl eller heteroaryl)-6-methyl-1,4-dihydropyridin-3,5- dicarboxylsyreestere og deres anvendelse til behandling af cardiovasculaere lidelser samt farmaceutiske praeparater indeholdende disse forbindelser
ATE340791T1 (de)	2006-10-15	Herstellung und verwendung von 2-substituierten 5-oxo-3-pyrazolidincarboxylaten
RU98117457A (ru)	2000-09-27	Соединения производных окса- и тиа-диазола, способ их получения, фармацевтическая композиция и способы лечения
NO20082226L (no)	2008-07-01	6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
KR970704692A (ko)	1997-09-06	류코트리엔 생합성의 억제제로서의 이미녹시카복실레이트 및 이의 유도체(Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis)
NO176176B (no)	1994-11-07	Analogifremgangsmåte for fremstilling av terapeutisk aktive arylsulfonamider
NO960441L (no)	1996-02-02	Benzopyraner og farmasöytiske forbindelser inneholdende dem
KR910007928A (ko)	1991-05-30	신규 벤조[1,8] 나프티리딘 유도체, 그의 제조 및 그를 함유하는 조성물
KR880001593A (ko)	1988-04-25	4-(아로일아미노)피페리딘부탄아미드 유도체
KR930004234A (ko)	1993-03-22	메타노안트라센 화합물